Since the United States Food and Drug Administration’s ban on all products containing propoxyphene in November 2010, there has been an exponential growth in Darvon Lawsuits being filed. Recently three Louisiana Residents have filed lawsuits against several of the drug manufacturers that produce and sell the drug, claiming that the painkiller caused them to sustain cardiac injuries.
Billy Lambert, Gladys Delaune, and Margaret Seagraves filed suit in U.S. District Court for the Eastern District of Louisiana on March 4, 2011. These three are accusing the companies that have direct history with Darvon and Darvocet, including Xanodyne Pharmaceuticals, AAIPharma Services, Eli Lilly and Company, Teva Pharmaceuticals USA, and Qualitest Pharmaceuticals. The original developer of Darvon (1957) and Darvocet (1972) was Eli Lily and Company before selling the drugs to AAIPharma in 2002, after which Xanodyne purchased the rights for Darvon and Darvocet after AAI became insolvent. Teva and Qualitest are two of the generic manufacturers of propoxyphene, there are however others.
The Louisiana residents claim that the drugs taken contained propoxyphene and caused them to develop serious, life-threatening heart conditions, including wide complex tachycardia, a type of cardiac rhythm abnormality. The lawsuits also claim that the drug companies knew or had a reasonable amount of knowledge that propoxyphene can potentially cause the cardiac injuries the plaintiffs. And now with the independent study done by Xanodyne Pharmaceuticals showed that propoxyphene can cause heart abnormalities in patients with no prior heart problems even with the normal amount of prescription, the case against the pharmaceutical companies is overwhelming.
There is a schedule for Multidistrict Litigation (MDL) later this month to see if all the Darvon and Darvocet Lawsuits should be placed under a single judge for pretrial proceedings. The MDL would allow all those who have been injured by Darvon or Darvocet to save a significant amount of time and money.
The majority of the new Darvon lawsuits being filed are claiming that the pharmaceutical companies failed to warn them of the side effects of propoxyphene drugs Darvon and Darvocet. If the drug companies had sufficient amount of knowledge about the side effects of their drugs, they are legally bound to warn their customers about them, and since no warning was given those who have been injured will see their day in court.
{ 0 коментара… прибавете свой сега }